The Urban and Shelley Meyer Professorship in Cancer will advance cancer research through innovative ideas, novel therapies, state-of-the-art technology, basic and translational research, and other initiatives to more quickly improve patient treatments and outcomes.
Guo is a tenured professor in the Department of Radiation Oncology. His laboratory team’s research focuses on understanding metabolic reprogramming in malignancy and aims to identify novel molecular targets and effective therapeutic strategies for cancer. Guo joined the OSUCCC – James in 2011, and in 2015 his study investigating cancer lipid metabolism was featured as one of “Ten Breakthrough and Insights for Cancer Research” by the American Cancer Society. Guo’s team has four active National Institutes of Health (NIH) R01 grants to support their ongoing research.
“I am very excited for the appointment of this professorship. Our research aims to translate scientific discoveries into new therapies for patients, and this will have a profound impact on our work to create a cancer-free world,” says Guo.
The Urban Meyer III and Shelley Meyer Chair for Cancer Research
Timothy M. Pawlik, MD, PhD, MPH, professor and chair of the Department of Surgery, was named the Urban Meyer III and Shelley Meyer Chair for Cancer Research in 2016. He has been upholding his commitment to work “above the line” in caring for patients, delivering state-of-the-art treatment and performing innovative research in pursuit of a cancer-free world.
Pawlik’s research is contributing to the understanding, prognosis, staging and care of patients with complex liver and pancreas cancers. His research also includes understanding how social vulnerability, race and other social determinants of health impact the ability of patients to receive quality care and achieve the best possible outcomes.